CME Group Inc. (NASDAQ:CME) Shares Purchased by Capital International Ltd. CA

18 Apr 2025, 11:02 by Renee Jackson · The Cerbat Gem

Capital International Ltd. CA raised its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 14.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 54,479 shares of the financial services provider’s stock after acquiring an additional 6,953 shares during the period. Capital International Ltd. CA’s holdings in CME Group were worth $12,652,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in the stock. SJS Investment Consulting Inc. lifted its holdings in shares of CME Group by 570.6% in the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 97 shares during the last quarter. New Age Alpha Advisors LLC grew its stake in CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after buying an additional 43 shares during the last quarter. Financial Life Planners acquired a new stake in CME Group in the fourth quarter worth $32,000. Knuff & Co LLC bought a new stake in CME Group in the fourth quarter valued at $33,000. Finally, Fortitude Family Office LLC boosted its holdings in shares of CME Group by 120.3% during the fourth quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after acquiring an additional 83 shares during the period. 87.75% of the stock is owned by institutional investors.

Insider Activity

In other CME Group news, insider Hilda Harris Piell sold 3,984 shares of CME Group stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total transaction of $997,872.48. Following the transaction, the insider now directly owns 27,046 shares in the company, valued at approximately $6,774,211.62. The trade was a 12.84 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Julie Winkler sold 11,592 shares of the business’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the sale, the insider now directly owns 21,885 shares in the company, valued at approximately $5,453,085.45. This trade represents a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 27,076 shares of company stock valued at $6,871,496 over the last three months. Insiders own 0.30% of the company’s stock.

CME Group Price Performance

Shares of NASDAQ CME opened at $262.53 on Friday. The firm has a 50-day moving average of $256.78 and a two-hundred day moving average of $240.16. The company has a market capitalization of $94.60 billion, a price-to-earnings ratio of 27.15, a PEG ratio of 6.76 and a beta of 0.43. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a twelve month low of $190.70 and a twelve month high of $273.42.

CME Group (NASDAQ:CME – Get Free Report) last issued its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, topping analysts’ consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. As a group, analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th were given a dividend of $1.25 per share. The ex-dividend date was Friday, March 7th. This is a positive change from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.90%. CME Group’s payout ratio is 51.71%.

Wall Street Analysts Forecast Growth

CME has been the topic of a number of analyst reports. Barclays increased their price objective on shares of CME Group from $263.00 to $279.00 and gave the stock an “equal weight” rating in a report on Monday, April 7th. Citigroup lowered shares of CME Group from a “buy” rating to a “neutral” rating and dropped their price target for the company from $255.00 to $250.00 in a research note on Monday, January 6th. Erste Group Bank raised CME Group to a “strong-buy” rating in a report on Monday, March 17th. Bank of America increased their price objective on CME Group from $200.00 to $219.00 and gave the stock an “underperform” rating in a report on Wednesday, April 2nd. Finally, Oppenheimer lifted their target price on CME Group from $269.00 to $279.00 and gave the company an “outperform” rating in a research note on Friday, April 11th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, CME Group presently has an average rating of “Hold” and an average price target of $247.47.

View Our Latest Report on CME Group

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.